Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010

Source Summary

VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated June 23, 2026, the initiation of polymer process development and analytical characterization activities being conducted by Nanosoft Polymers ("Nanosoft") in support of ONC010, the Company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase ("PNKP") inhibitor.